Institute of Molecular Biomedicine

IMBM is a research institute of the Faculty of Medicine at the Comenius University in Slovakia. We are located in Bratislava, both in the heart of the capital’s old town at Sasinkova 4, and in the Biomedical research center of the Slovak Academy of Sciences at Dubravská street 9.  The mission of IMBM is simple: to do (and enjoy doing) science. As of our staff, we have a vast range of educational background – from molecular biology, biophysics, biotechnology or physiology, up to medicine. While we believe that interdisciplinarity is a key scientific value. Furthermore, our partnerships extend to collaborating with clinicians and complementary research institutes all around the globe (Aachen, Gothenburg, New York, Boston, Hradec Králové…). This is a great enrichment to our  esearch. Of course, our institute is also home for many PhD students that are trained here in experimental and laboratory medicine, as well as undergraduate and graduate students that work on their bachelor/master/doctoral thesis with us. Moreover, our teaching takes place at the Faculty of Medicine and the Faculty of Natural  Sciences of the Comenius University. Ultimately, IMBM is an institute of open-minded people, scientists, who share their devotion to science. If you share this devotion with us, apply and come join us at the Institute of Molecular Biomedicine in Bratislava.

 

News

Doctoral Dissertation Defense: MUDr. Igor Riečanský, PhD.

The defense of the doctoral dissertation of MUDr. Igor Riečanský, PhD. will be held on November 20, 2024 at 2:00 PM at the Institute of Molecular Biomedicine in the Pavilion of Medical Sciences of the Slovak Academy of Sciences, block B, 6th floor. The defense will be carried out in a hybrid form, the link for Teams is here.

November 20, 2024

Meeting with Nobel Prize Laureates for Physiology and Medicine

Associate professor Roman Gardlík participated in the prestigious mRNA conference in Szeged, (Hungary, November 7-8, 2024), where new advancements in mRNA technologies were discussed. The keynote speakers included the 2023 Nobel Prize laureates in Physiology or Medicine, Katalin Karikó and Drew Weissman, as well as the founder of BioNTech, Ugur Sahin, who made significant contributions to the development of mRNA vaccines. For more information about the event, visit this link.

November 20, 2024

Science

Projects

  • KEGA: KEGA 071UK-4/2022 Innovation of Practical Biomedical Research Courses for Doctoral Students
  • APVV: APVV-20-0472 Rapid identification of pathogens in sepsis patients using third-generation nanopore real-time sequencing
  • APVV: APVV-22-0554 Deoxyribonuclease 1l3 in the biology of extracellular DNA

Published papers

  • Extracellular DNA and Deoxyribonuclease Activity as Prognostic Markers in Sepsis
  • Altered sex differences related to food intake, hedonic preference, and FosB/deltaFosB expression within central neural circuit involved in homeostatic and hedonic food intake regulation in Shank3B mouse model of autism spectrum disorder
  • Oxidative Stress Markers and Na,K-ATPase Enzyme Kinetics Are Altered in the Cerebellum of Zucker Diabetic Fatty fa/fa Rats: A Comparison with Lean fa/+ and Wistar Rats